When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With KZIA Stock Today?
Kazia Therapeutics Ltd (KZIA) stock has risen 4.75% while the S&P 500 is down -0.96% as of 9:34 AM on Thursday, Jul 6. KZIA is higher by $0.06 from the previous closing price of $1.17 on volume of 5,928,393 shares. Over the past year the S&P 500 is higher by 14.94% while KZIA is down -70.50%. KZIA lost -$1.21 per share in the over the last 12 months.
To see InvestorsObserver's Sentiment Score for Kazia Therapeutics Ltd click here.
More About Kazia Therapeutics Ltd
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.
Click Here to get the full Stock Report for Kazia Therapeutics Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
